Chronic Poly I:C treatment, via activation of Tlr3 and the RIG-I-like receptors, results in the production of IL-6 and IFNγ that can, when provided chronically as a model for cachexia, lead to a progressive weight loss [40]. Here, TLR3 is linked to Cachexia.